Expression of insulin-like growth factor-I in lesional and non-lesional skin of patients with morphoea
Summary Background Morphoea (scleroderma) is a chronic disorder characterized by circumscribed sclerotic plaques with the hallmark of increased fibroblast activation and fibrosis. Through its effect on connective tissue cells and immune cells, insulin‐like growth factor (IGF)‐I has been found to pl...
Gespeichert in:
Veröffentlicht in: | British journal of dermatology (1951) 2008-07, Vol.159 (1), p.86-90 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Summary
Background Morphoea (scleroderma) is a chronic disorder characterized by circumscribed sclerotic plaques with the hallmark of increased fibroblast activation and fibrosis. Through its effect on connective tissue cells and immune cells, insulin‐like growth factor (IGF)‐I has been found to play a role in some autoimmune connective tissue diseases and has been implicated in the pathogenesis of several fibrotic disorders.
Objectives To evaluate the role of IGF‐I in the pathogenesis of morphoea.
Methods The study was carried out on 15 patients with morphoea and nine healthy controls. Two 5‐mm punch skin biopsies were taken from every patient (one from lesional and one from non‐lesional skin) and a single biopsy was taken from the normal skin of each control. A 10‐mL blood sample was also taken from each patient and control. Quantitative detection of tissue and serum levels of IGF‐I was done using an enzyme‐linked immunosorbent assay technique.
Results IGF‐I in lesional skin was significantly higher than in non‐lesional and control skin (P = 0·001 and P = 0·021, respectively). Moreover, a significantly higher level of IGF‐I was detected in patient serum when compared with control serum (P |
---|---|
ISSN: | 0007-0963 1365-2133 |
DOI: | 10.1111/j.1365-2133.2008.08592.x |